The company was founded earlier this year and is poaching university scientists with salaries as high as $1 million and promises that they can pursue their own research on how cells age and how to reverse that process, according to a report from MIT Tech Review.
Altos Labs also counts Bezos among its investors, the report said, citing people briefed by the company.
Bezos’ investment office Bezos Expeditions did not return The Post’s request for comment.
Bezos, 57, is currently the world’s richest man with a net worth of about $201 billion, according to Bloomberg’s Billionaires Index.
He has funded similar research in the past, previously investing in anti-aging company Unity Biotechnology.
Bezos resigned as CEO of Amazon in July and said earlier this year that he would spend more time on philanthropy and passion projects, like his space company Blue Origin.
Altos was incorporated in Delaware this year and a securities disclosure filed in California in June indicates the company has raised at least $270 million, according to MIT Tech Review.
Yuri Milner, a Russian-born billionaire who made a fortune on Facebook and other tech investments, also has a stake in Altos, MIT Tech Review reported.